National University Cancer Institute, Singapore
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
- Oncology 989
- Cancer Cells and Metastasis 140
- Cancer Research 537
- Cancer Genomics and Diagnostics 161
- Top scholars
- Dietmar W. HutmacherJean Paul ThieryGautam SethiAlan Prem KumarRuby Yun‐Ju HuangWee Joo ChngEdward Kai‐Hua ChowH. Phillip Koeffler
- Journals
- Blood (157 papers)Journal of Clinical Oncology (144 papers)Annals of Oncology (84 papers)PLoS ONE (78 papers)Oncotarget (72 papers)
- Partner nations
- SingaporeUnited StatesChina
In The Last Decade
National University Cancer Institute, Singapore
3.4k papers receiving 140.3k citations
Peers
Comparison fields: 5 of 235
- Cancer Research 28.0k
- Oncology 33.4k
- Molecular Biology 67.2k
- Hematology 8.5k
- Immunology 14.6k
Countries citing scholars working at National University Cancer Institute, Singapore
This map shows the geographic impact of research produced by authors working at National University Cancer Institute, Singapore. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at National University Cancer Institute, Singapore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites National University Cancer Institute, Singapore more than expected).
Fields of papers published by authors at National University Cancer Institute, Singapore
This network shows the impact of papers affiliated with National University Cancer Institute, Singapore at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with National University Cancer Institute, Singapore at the time of their publication.
About National University Cancer Institute, Singapore
In recent decades, authors affiliated with National University Cancer Institute, Singapore have published 3.9k papers, which have received a total of 157.8k indexed citations . Scholars at this organization have produced 989 papers in Oncology, 537 papers in Cancer Research, 400 papers in Hematology, 1.5k papers in Molecular Biology and 329 papers in Immunology on the topics of Lung Cancer Treatments and Mutations (201 papers), Epigenetics and DNA Methylation (196 papers), Acute Myeloid Leukemia Research (177 papers), RNA modifications and cancer (173 papers), Cancer Genomics and Diagnostics (161 papers), Multiple Myeloma Research and Treatments (146 papers), Cancer Cells and Metastasis (140 papers) and Protein Degradation and Inhibitors (135 papers). Their work is cited by papers focused on Cancer Research (28.0k citations), Oncology (33.4k citations), Molecular Biology (67.2k citations), Hematology (8.5k citations) and Immunology (14.6k citations). Authors at National University Cancer Institute, Singapore collaborate with scholars in Singapore, United States and China and have published in prestigious journals including Blood, Journal of Clinical Oncology, Annals of Oncology, PLoS ONE and Oncotarget. Some of National University Cancer Institute, Singapore's most productive authors include Dietmar W. Hutmacher, Jean Paul Thiery, Gautam Sethi, Alan Prem Kumar, Ruby Yun‐Ju Huang, Wee Joo Chng, Edward Kai‐Hua Chow, H. Phillip Koeffler, Ross A. Soo and Rebecca Jackson.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.